"10.1371_journal.pone.0087658","plos one","2014-02-03T00:00:00Z","Bryony N Parsons; Paul Wigley; Hannah L Simpson; Jonathan M Williams; Suzie Humphrey; Anne-Marie Salisbury; Alastair J M Watson; Stephen C Fry; David O'Brien; Carol L Roberts; Niamh O'Kennedy; Åsa V Keita; Johan D Söderholm; Jonathan M Rhodes; Barry J Campbell","Gastroenterology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom; Infection Biology, Institute of Infection and Global Health, University of Liverpool, Leahurst, United Kingdom; Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, United Kingdom; The Edinburgh Cell Wall Group, Institute of Molecular Plant Sciences, University of Edinburgh, Edinburgh, United Kingdom; Provexis plc, c/o Rowett Institute of Nutrition and Health, Aberdeen, United Kingdom; Clinical and Experimental Medicine, Division of Surgery, Faculty of Health Sciences, Linköping University, Linköping, Sweden","¶ These authors also contributed equally to this work.","JMR is/has been a member of advisory boards for Atlantic, Procter & Gamble and Falk, has received speaking honoraria from Abbott, Falk, Ferring, Glaxo Smith Kline, Procter & Gamble and Schering Plough and, with the University of Liverpool and Provexis plc, holds a patent for use of a soluble fibre preparation as maintenance therapy for Crohns disease. JMR, BJC, PW and AJMW have received support from Provexis plc. NO is a current employee, and CLR and DO were former employees, of Provexis plc. BJC has received a speaking honorarium from Amgen Inc. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2014","02","Bryony N Parsons","BNP",15,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
